Skip to content
    BioTrack Capital logo

    BioTrack Capital

    Shanghai, ChinaFounded 2017

    BioTrack Capital is a venture capital firm founded in 2017 and based in Shanghai, China. The firm focuses on investing in and incubating early-stage biotech, medtech, and healthcare companies across China.

    42% of their portfolio is in Biotech & Life Sciences. Deal activity increased 33% year-over-year (4 deals in the last 12 months). Their most common stage is series-a (50% of deals). Average disclosed round size is $135.3M (across 16 rounds with reported amounts).

    Find people at BioTrack Capital on Goldilocks AI

    Portfolio

    21

    Fund Size

    $250M

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Feng Tao

    Feng Tao

    Founding Partner

    Kevin Chen

    Kevin Chen

    Founding Partner & CEO

    Lisa Lei

    Lisa Lei

    Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    26 investments
    CompanyRoundAmountDate
    SSyneron BioSeries B$150MMar 2026
    BlossomHill Therapeutics logoBlossomHill TherapeuticsSeries B$84MDec 2025
    Rapafusyn logoRapafusynSeries A$44MSep 2025
    MMinghui PharmaceuticalIpo$131MAug 2025
    PPAQ TherapeuticsSeries B$39MMay 2025
    Rapafusyn logoRapafusynSeries A$44MJan 2025
    Rona Therapeutics logoRona TherapeuticsSeries A$35MJul 2024
    Rona logoRonaSeries A$35MJul 2024
    Brise Pharmaceuticals logoBrise PharmaceuticalsSeries A$20MApr 2024
    OnCusp logoOnCuspSeries A$100MJan 2024
    Sirius Therapeutics logoSirius TherapeuticsSeries B$50MOct 2023
    Pyrotech logoPyrotechSeries AJul 2023
    AAstraBioSeries AJun 2022
    CCarcell BiopharmaUnknownNov 2021
    Exegenesis Bio logoExegenesis BioSeries B$50MJun 2021
    Edigene logoEdigeneSeries BApr 2021
    OnQuality logoOnQualitySeries A$20MMar 2021
    HHC ScientificSeries BJan 2021
    Shanton logoShantonSeries A$31.2MDec 2020
    Htdk logoHtdkSeries B$1.2BJul 2020
    HHC ScientificSeries AJan 2020
    HHC ScientificSeries AJan 2019
    OnCusp logoOnCuspSeed
    MMinghui PharmaUnknown$131M
    HHaihe PharmaceuticalSeries A
    Page 1 of 2

    Top Co-Investors

    Last updated: 8 September 2026